Skip to main content

Ubiquitination

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer
  • 29 Accesses

Definition

It is the covalent modification of a protein by conjugation to ubiquitin (Fig. 1). Ubiquitin is a small, 76-residue protein found in all eukaryotes. Conjugates are formed through the ligation of the C-terminus of ubiquitin to the ε-amino groups of protein lysine residues. The major, but not sole, function of ubiquitination is to target proteins for degradation by the proteasome. A large number of proteins are substrates for this regulatory pathway. Efficient targeting of proteins for degradation usually involves formation of a multiubiquitin chain on the target protein. Such chains are characterized by specific ubiquitin-ubiquitin linkages.

Fig. 1
figure 1

The proteasome cycle in protein degradation. Ubiquitin is shown as a large dot, and the peptidase sites are shown as scissors. For simplicity, the 26S particle is shown with a single regulatory particle, and the 19S particle is shown without the protein mass that occupies the mouth of the wedge. Degradation of the substrate to...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Boisvert RA, Howlett NG (2014) The fanconi anemia ID2 complex: Dueling saxes at the crossroads. Cell Cycle 13(19):2999–3015. doi:10.4161/15384101.2014.956475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Curr Opin Hematol (2015) The role of aberrant proteolysis in lymphomagenesis. 22(4):369–78. doi:10.1097/MOH.0000000000000156

    Google Scholar 

  • de Thé H (2015) Lessons taught by acute promyelocytic leukemia cure. Lancet 386(9990):247–248. doi:10.1016/S0140-6736(15)61278-8

    Article  PubMed  Google Scholar 

  • Deshaies RJ (2014) Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy. BMC Biol 12:94

    Article  PubMed  PubMed Central  Google Scholar 

  • Elledge SJ, Harper JW (1998) The role of protein stability in the cell cycle and cancer. Biochim Biophys Acta 1377:M61–M70

    CAS  PubMed  Google Scholar 

  • Fink EC, Ebert BL (2015) The novel mechanism of lenalidomide activity. Blood 126(21):2366–2369

    Article  CAS  PubMed  Google Scholar 

  • Heo J, Eki R, Abbas T (2016) Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis. Semin Cancer Biol 36:33–51

    Article  CAS  PubMed  Google Scholar 

  • Massoumi R, Paus R (2007) Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. Bioessays 29:1203–1214

    Article  CAS  PubMed  Google Scholar 

  • Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20(11):1242–1253

    Article  CAS  PubMed  Google Scholar 

  • Rubin DM, Finley D (1995) The proteasome: a protein-degrading organelle? Curr Biol 5:854–858

    Article  CAS  PubMed  Google Scholar 

  • Sahasrabuddhe AA, Elenitoba-Johnson KS (2015) The role of aberrant proteolysis in lymphomagenesis. Curr Opin Hematol 22(4):369–378. doi:10.1097/MOH.0000000000000156

    CAS  PubMed  Google Scholar 

See Also

  • (2012) Benign Tumor. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 381. doi:10.1007/978-3-642-16483-5_579

    Google Scholar 

  • (2012) CYLD. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1036. doi:10.1007/978-3-642-16483-5_1442

    Google Scholar 

  • (2012) De-ubiquitinating Enzymes. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1104. doi:10.1007/978-3-642-16483-5_1593

    Google Scholar 

  • (2012) FOS. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1446. doi:10.1007/978-3-642-16483-5_2252

    Google Scholar 

  • (2012) Glycogen Synthase Kinase-3. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1570. doi:10.1007/978-3-642-16483-5_2448

    Google Scholar 

  • (2012) JUN. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1929. doi:10.1007/978-3-642-16483-5_3186

    Google Scholar 

  • (2012) P53. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2747. doi:10.1007/978-3-642-16483-5_4331

    Google Scholar 

  • (2012) Ubiquitin. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3825. doi:10.1007/978-3-642-16483-5_6083

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Finley .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Finley, D. (2014). Ubiquitination. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_6087-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_6087-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics